Blocklisting Interim Review
GlaxoSmithKline PLC
08 November 2007
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and
provided to an RIS.
Date: 8 November 2007
Name of applicant: GlaxoSmithKline plc
Name of scheme: GlaxoSmithKline Share Option Plan - Ordinary Shares
Period of return: From: 1 June 2007 To: 7 November 2007
Balance of unallotted securities under scheme(s) from -2,016,067
previous return:
Plus: The amount by which the block scheme(s) has been 5,000,000
increased since the date of the last return (if any
increase has been applied for):
Less: Number of securities issued/allotted under 493,671
scheme(s) during period (see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted 2,490,262
at end of period:
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and
provided to an RIS.
Date: 8 November 2007
Name of applicant: GlaxoSmithKline plc
Name of scheme: GlaxoSmithKline Share Option Plan - ADS
Period of return: From: 1 June 2007 To: 7 November 2007
Balance of unallotted securities under scheme(s) from -25,762,318
previous return:
Plus: The amount by which the block scheme(s) has been 32,000,000
increased since the date of the last return (if any
increase has been applied for):
Less: Number of securities issued/allotted under 3,628,546
scheme(s) during period (see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted 2,609,136
at end of period:
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and
provided to an RIS.
Date: 8 November 2007
Name of applicant: GlaxoSmithKline plc
Name of scheme: Glaxo Wellcome UK Share Option Scheme
Period of return: From: 1 June 2007 To: 7 November 2007
Balance of unallotted securities under scheme(s) from 5,210,158
previous return:
Plus: The amount by which the block scheme(s) has been 0
increased since the date of the last return (if any
increase has been applied for):
Less: Number of securities issued/allotted under 90,408
scheme(s) during period (see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted 5,119,750
at end of period:
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and
provided to an RIS.
Date: 8 November 2007
Name of applicant: GlaxoSmithKline plc
Name of scheme: Glaxo Wellcome International Share Option Scheme
Period of return: From: 1 June 2007 To: 7 November 2007
Balance of unallotted securities under scheme(s) from 13,582,536
previous return:
Plus: The amount by which the block scheme(s) has been 0
increased since the date of the last return (if any
increase has been applied for):
Less: Number of securities issued/allotted under 315,380
scheme(s) during period (see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted 13,267,156
at end of period:
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and
provided to an RIS.
Date: 8 November 2007
Name of applicant: GlaxoSmithKline plc
Name of scheme: Glaxo Group Limited Share Option Scheme
Period of return: From: 1 June 2007 To: 7 November 2007
Balance of unallotted securities under scheme(s) from -679
previous return:
Plus: The amount by which the block scheme(s) has been 679
increased since the date of the last return (if any
increase has been applied for):
Less: Number of securities issued/allotted under 0
scheme(s) during period (see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted 0
at end of period:
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and
provided to an RIS.
Date: 8 November 2007
Name of applicant: GlaxoSmithKline plc
Name of scheme: Glaxo Wellcome 1999 Share Option Plan
Period of return: From: 1 June 2007 To: 7 November 2007
Balance of unallotted securities under scheme(s) from 1,040,000
previous return:
Plus: The amount by which the block scheme(s) has been 0
increased since the date of the last return (if any
increase has been applied for):
Less: Number of securities issued/allotted under 0
scheme(s) during period (see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted 1,040,000
at end of period:
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and
provided to an RIS.
Date: 8 November 2007
Name of applicant: GlaxoSmithKline plc
Name of scheme: SmithKline Beecham 1989 Executive Share Option Plan -
Approved - Ordinary Shares
Period of return: From: 1 June 2007 To: 7 November 2007
Balance of unallotted securities under scheme(s) from 241,549
previous return:
Plus: The amount by which the block scheme(s) has been 0
increased since the date of the last return (if any
increase has been applied for):
Less: Number of securities issued/allotted under 37,307
scheme(s) during period (see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted 204,242
at end of period:
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and
provided to an RIS.
Date: 8 November 2007
Name of applicant: GlaxoSmithKline plc
Name of scheme: SmithKline Beecham 1989 Executive Share Option Plan -
Unapproved - ADS
Period of return: From: 1 June 2007 To: 7 November 2007
Balance of unallotted securities under scheme(s) from 275,420
previous return:
Plus: The amount by which the block scheme(s) has been 0
increased since the date of the last return (if any
increase has been applied for):
Less: Number of securities issued/allotted under 0
scheme(s) during period (see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted 275,420
at end of period:
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and
provided to an RIS.
Date: 8 November 2007
Name of applicant: GlaxoSmithKline plc
Name of scheme: SmithKline Beecham 1989 Executive Share Option Plan -
Unapproved - Ordinary Shares
Period of return: From: 1 June 2007 To: 7 November 2007
Balance of unallotted securities under scheme(s) from -63,812
previous return:
Plus: The amount by which the block scheme(s) has been 163,812
increased since the date of the last return (if any
increase has been applied for):
Less: Number of securities issued/allotted under 0
scheme(s) during period (see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted 100,000
at end of period:
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and
provided to an RIS.
Date: 8 November 2007
Name of applicant: GlaxoSmithKline plc
Name of scheme: GlaxoSmithKline Savings Related Share Option Scheme
Period of return: From: 1 June 2007 To: 7 November 2007
Balance of unallotted securities under scheme(s) from 2,458,702
previous return:
Plus: The amount by which the block scheme(s) has been 0
increased since the date of the last return (if any
increase has been applied for):
Less: Number of securities issued/allotted under 63,706
scheme(s) during period (see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted 2,394,996
at end of period:
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
This information is provided by RNS
The company news service from the London Stock Exchange